<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Huang Lab ‚Äî Home</title>
  <link rel="stylesheet" href="style.css">
</head>
<body>
  <header>
    <h1>Huang Lab</h1>
    <h2 class="subtitle">Development and disease (leukemia and pediatric cancer)</h2>
    <nav>
      <a href="index.html">üè† Home</a> |
      <a href="xin.huang.html">üë©üèª‚Äçüíª Xin Huang</a> |
      <a href="news.html">üì∞ News</a> |
      <a href="team.html">üë• Team</a> |
      <a href="publications.html">üìö Publications</a> |
      <a href="resources.html">üß™ Resources</a> |
      <a href="#contact">‚úâÔ∏è Contact</a>
    </nav>
  </header>

  <main>
    <h1>Publications</h1>
    <ul class="publication-list">
  <li><strong>Huang, X.</strong> *, Li Y*, Zhang J*, Yan L, Zhao H, Ding L, Bhatara S, Yang X, Yoshimura S, Yang W, Karol SE, Inaba H, Mullighan C, Litzow M, Zhu X, Zhang Y, Stock W, Jain N, Jabbour E, Kornblau SM, Konopleva M, Pui CH, Paietta E, Evans W, Yu J, Yang JJ. Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia. <strong><em>Cancer Cell</em></strong> 42(4):552-567.e6  (2024). <a class="doi-link" href="https://doi.org/10.1016/j.ccell.2024.03.003" target="_blank"></a></li>

  <li><strong>Huang, X.</strong> *#, Hou X*, Li Y, Yang JJ, Yu J#. Protocol for predicting single-cell network-based gene activity landscape during human B cell development. <strong><em>STAR Protocols</em></strong> (2025). <a class="doi-link" href="https://doi.org/10.1016/j.xpro.2025.103614" target="_blank"></a></li>

  <li>Zhenhua Li et al. Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia. <strong><em>Nat Commun</em></strong> (2024). <a class="doi-link" href="https://doi.org/10.1038/s41467-025-56229-7" target="_blank"></a></li>

  <li>Anand G. Patel et al. A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity. <strong><em>bioRxiv</em></strong> (2024). <a class="doi-link" href="https://doi.org/10.1101/2024.01.07.574538" target="_blank"></a></li>

  <li>Li, Z., Chang, T. C., Junco, J. J., Devidas, M., Li, Y., Yang, W., <strong>Huang, X.</strong>, Hedges, D. J., Cheng, Z., Shago, M., Carroll, A. J., Heerema, N. A., Gastier-Foster, J. M., Wood, B. L., Borowitz, M. J., Sanclemente, L., Raetz, E. A., Hunger, S. P., Feingold, E., Rosser, T. C., Sherman, S. L., Loh, M. L., Mullighan, C. G., Yu, J., Wu, G., Lupo, P. J., Rabin, K. R. & Yang, J. J. Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia. <strong><em>Blood</em></strong> (2023). <a class="doi-link" href="https://doi.org/10.1182/blood.2023019765" target="_blank"></a></li>

  <li>Ding, L., Shi, H., Qian, C., Burdyshaw, C., Veloso, J. P., Khatamian, A., Pan, Q., Dhungana, Y., Xie, Z., Risch, I., Yang, X., <strong>Huang, X.</strong>, Yan, L., Rusch, M., Brewer, M., Yan, K. K., Chi, H. & Yu, J. scMINER: a mutual information-based framework for identifying hidden drivers from single-cell omics data. <strong><em>bioRxiv</em></strong> (2023). <a class="doi-link" href="https://doi.org/10.1101/2023.01.26.523391" target="_blank"></a></li>
  
  <li>Zhao, X., Wang, P., Diedrich, J. D., Smart, B., Reyes, N., Yoshimura S., Zhang, J., Yang, W., Barnett, K., Xu, B., Li, Z., <strong>Huang, X.</strong>, Yu J., Crews, K., Yeoh, A. E. J., Konopleva, M., Wei, C. L., Pui, C. H., Savic, D. & Yang, J. J. Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia. <strong><em>Nat Commun</em></strong> 13, 5401 (2022). <a class="doi-link" href="https://doi.org/10.1038/s41467-022-33143-w" target="_blank"></a></li>
  
  <li>Li, J., Dai, C., Xie, W., Zhang, H., <strong>Huang, X.</strong>, Chronis, C., Ye, Y. & Zhang, W. A One-step strategy to target essential factors with auxin-inducible degron system in mouse embryonic stem cells. <strong><em>Front Cell Dev Biol</em></strong> 10, 964119 (2022). <a class="doi-link" href="https://doi.org/10.3389/fcell.2022.964119" target="_blank"></a></li>
  
  <li>Patel, A. G. *, Chen, X. *, <strong>Huang, X.</strong> *, Clay, M. R., Komorova, N., Krasin, M. J., Pappo, A., Tillman, H., Orr, B. A., McEvoy, J., Gordon, B., Blankenship, K., Reilly, C., Zhou, X., Norrie, J. L., Karlstrom, A., Yu, J., Wodarz, D., Stewart, E. & Dyer, M. A. The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma. <strong><em>Dev Cell</em></strong> 57, 1226-1240 e1228 (2022). <a class="doi-link" href="https://doi.org/10.1016/j.devcel.2022.04.003" target="_blank"></a></li>
  
  <li>Yang, S. W. *, <strong>Huang, X.</strong> *, Lin, W., Min, J., Miller, D. J., Mayasundari, A., Rodrigues, P., Griffith, E. C., Gee, C. T., Li, L., Li, W., Lee, R. E., Rankovic, Z., Chen, T. & Potts, P. R. Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases. <strong><em>Nat Commun</em></strong> 11, 4931 (2020). <a class="doi-link" href="https://doi.org/10.1038/s41467-020-18708-x" target="_blank"></a></li>
  
  <li>Gocho, Y., Liu, J., Hu, J., Yang, W., Dharia, N. V., Zhang, J., Shi, H., Du, G., John, A., Lin, T. N., Hunt, J., <strong>Huang, X.</strong>, Ju, B., Rowland, L., Shi, L., Maxwell, D., Smart, B., Crews, K. R., Yang, W., Hagiwara, K., Zhang, Y., Roberts, K., Wang, H., Jabbour, E., Stock, W., Eisfelder, B., Paietta, E., Newman, S., Roti, G., Litzow, M., Easton, J., Zhang, J., Peng, J., Chi, H., Pounds, S., Relling, M. V., Inaba, H., Zhu, X., Kornblau, S., Pui, C. H., Konopleva, M., Teachey, D., Mullighan, C. G., Stegmaier, K., Evans, W. E., Yu, J. & Yang, J. J. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. <strong><em>Nat Cancer</em></strong> 2, 284-299 (2021). <a class="doi-link" href="https://doi.org/10.1038/s43018-020-00167-4" target="_blank"></a></li>
  
  <li>Zhu, Z., Li, C., Zeng, Y., Ding, J., Qu, Z., Gu, J., Ge, L., Tang, F., <strong>Huang, X.</strong>, Zhou, C., Wang, P., Zheng, D. & Jin, Y. PHB Associates with the HIRA Complex to Control an Epigenetic-Metabolic Circuit in Human ESCs. <strong><em>Cell Stem Cell</em></strong> 20, 274-289 e277 (2017). <a class="doi-link" href="https://doi.org/10.1016/j.stem.2016.11.002" target="_blank"></a></li>
  
  <li><strong>Huang, X.</strong>, Zheng, Y., Zhang, F., Wei, Z., Wang, Y., Carrell, R. W., Read, R. J., Chen, G. Q. & Zhou, A. Molecular Mechanism of Z alpha1-Antitrypsin Deficiency. <strong><em>J Biol Chem</em></strong> 291, 15674-15686 (2016). <a class="doi-link" href="https://doi.org/10.1074/jbc.M116.727826" target="_blank"></a></li>
  
  <li>Wei, H., Cai, H., Wu, J., Wei, Z., Zhang, F., <strong>Huang, X.</strong>, Ma, L., Feng, L., Zhang, R. & Wang, Y. Heparin binds lamprey angiotensinogen and promotes thrombin inhibition through a template mechanism. <strong><em>J Biol Chem</em></strong> 291, 24900-24911 (2016).</li>
  
  <li>Liu, C. X., Yin, Q. Q., Zhou, H. C., Wu, Y. L., Pu, J. X., Xia, L., Liu, W., <strong>Huang, X.</strong>, Jiang, T., Wu, M. X., He, L. C., Zhao, Y. X., Wang, X. L., Xiao, W. L., Chen, H. Z., Zhao, Q., Zhou, A. W., Wang, L. S., Sun, H. D. & Chen, G. Q. Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells. <strong><em>Nat Chem Biol</em></strong> 8, 486-493 (2012). <a class="doi-link" href="https://doi.org/10.1038/nchembio.935" target="_blank"></a></li>
  
  <li>Shi, Y., Hu, G., Su, J., Li, W., Chen, Q., Shou, P., Xu, C., Chen X., Huang, Y., Zhu, Z., <strong>Huang, X.</strong>, Han, X., Xie, N. & Ren, G. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. <strong><em>Cell Res</em></strong> 20, 510-518 (2010). <a class="doi-link" href="https://doi.org/10.1038/cr.2010.44" target="_blank"></a></li>
</ul>

  </main>
</body>
</html>